Clinical trial

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

NCT04871919

Study summary

ClinicalTrials.gov

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Filgotinib Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2021-05-11

PhaseN/A

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

FilgotinibDRUG

Sponsors & collaborators

Alfasigma S.p.A.lead sponsor

Mapped research locations

BerlinGermany4 BarcelonaSpain2 LondonUnited Kingdom2 HamburgGermany2 SevilleSpain2 BrusselsBelgium2 RomaItaly2 MünchenGermany2 LeipzigGermany2 GenkBelgium2 MilanItaly1 LeuvenBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04871919 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.